These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Park SH, Kim HY, Min JK. Immunol Lett; 2009 Apr 27; 123(2):138-43. PubMed ID: 19428561 [Abstract] [Full Text] [Related]
9. IRF-7 Mediates Type I IFN Responses in Endotoxin-Challenged Mice. Sin WX, Yeong JP, Lim TJF, Su IH, Connolly JE, Chin KC. Front Immunol; 2020 Apr 27; 11():640. PubMed ID: 32373120 [Abstract] [Full Text] [Related]
13. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. Yasuda K, Richez C, Maciaszek JW, Agrawal N, Akira S, Marshak-Rothstein A, Rifkin IR. J Immunol; 2007 Jun 01; 178(11):6876-85. PubMed ID: 17513736 [Abstract] [Full Text] [Related]
14. Plasmacytoid dendritic cell-derived IFN-α promotes murine liver ischemia/reperfusion injury by induction of hepatocyte IRF-1. Castellaneta A, Yoshida O, Kimura S, Yokota S, Geller DA, Murase N, Thomson AW. Hepatology; 2014 Jul 01; 60(1):267-77. PubMed ID: 24493010 [Abstract] [Full Text] [Related]
15. Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice. Conrad E, Resch TK, Gogesch P, Kalinke U, Bechmann I, Bogdan C, Waibler Z. Hepatology; 2014 Apr 01; 59(4):1555-63. PubMed ID: 24677196 [Abstract] [Full Text] [Related]
17. The dual functions of IL-1 receptor-associated kinase 2 in TLR9-mediated IFN and proinflammatory cytokine production. Wan Y, Kim TW, Yu M, Zhou H, Yamashita M, Kang Z, Yin W, Wang JA, Thomas J, Sen GC, Stark GR, Li X. J Immunol; 2011 Mar 01; 186(5):3006-14. PubMed ID: 21270393 [Abstract] [Full Text] [Related]
18. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. Simmons DP, Canaday DH, Liu Y, Li Q, Huang A, Boom WH, Harding CV. J Immunol; 2010 Aug 15; 185(4):2405-15. PubMed ID: 20660347 [Abstract] [Full Text] [Related]
19. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, Matsuda M, Coban C, Ishii KJ, Kawai T, Takeuchi O, Akira S. J Exp Med; 2005 Mar 21; 201(6):915-23. PubMed ID: 15767370 [Abstract] [Full Text] [Related]
20. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. Gotoh K, Tanaka Y, Nishikimi A, Nakamura R, Yamada H, Maeda N, Ishikawa T, Hoshino K, Uruno T, Cao Q, Higashi S, Kawaguchi Y, Enjoji M, Takayanagi R, Kaisho T, Yoshikai Y, Fukui Y. J Exp Med; 2010 Apr 12; 207(4):721-30. PubMed ID: 20231379 [Abstract] [Full Text] [Related] Page: [Next] [New Search]